Imper Vera bought CTKB
June 10, 2026 · Form 4 insider transaction
Imper Vera bought 43,973 shares of Cytek Biosciences, Inc., a transaction worth N/A. The trade was recorded as option exercise and disclosed on an SEC Form 4, filed 2 days after the transaction.
Direction
Acquired (buy-side)
Shares
43,973
Price
N/A
Total value
N/A
InsiderImper Vera
RoleDirector
SecurityCommon Stock
Transaction codeM: Option exercise
Transaction dateJune 10, 2026
Filing dateJune 12, 2026
Shares owned after59,679
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Each Restricted Stock Unit (the "RSU Award") represents a contingent right to receive one share of the Issuer's common stock.